Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes.

BACKGROUND Although the carcinogenic potential of iron has been shown, evidence from observational studies that have linked serum iron variables and cancer outcomes has been inconsistent. OBJECTIVE We investigated whether higher iron concentrations increased risk of cancer outcomes. DESIGN A prospective examination of iron biomarkers as independent risk factors for cancer was assessed in 1597 men and 1795 women aged 25-79 y who participated in the 1994/1995 Busselton Health Survey and had relevant data, no history of cancer before the survey, and serum ferritin concentrations ≥20 μg/L. Follow-up for incident cancers and death from cancer was available to 2010. Proportional hazards regression modeling was performed to investigate if iron status predicted cancer incidence and mortality. RESULTS After adjustments for age, smoking, drinking, anthropometric and biochemical variables, or menopausal status (breast cancer), higher serum iron concentrations and transferrin saturation were associated with increased risks of incident nonskin cancer [HR for iron: 1.83 (95% CI: 1.21, 2.76; P < 0.01); HR for transferrin saturation: 1.68 (95% CI: 1.18, 2.38; P < 0.01)] including breast cancer [HR for iron: 2.45 (95% CI:1.12, 5.34; P < 0.05); HR for transferrin saturation: 1.90 (95% CI:1.02, 3.56; P < 0.05)] in women. Transferrin saturation was also associated with a greater risk of cancer death (HR: 2.48; 95% CI: 1.28, 4.82; P < 0.01). In men, higher iron concentrations were associated with reduced risks of incident nonskin cancer (HR: 0.65; 95% CI: 0.42, 0.99; P < 0.05) including colorectal cancer (HR: 0.34; 95% CI: 0.12, 0.95; P < 0.05). There was no association between serum iron and colorectal cancer risk in women. Serum ferritin was not associated with cancer risk or cancer death. CONCLUSIONS Higher transferrin saturation or serum iron concentrations were associated with increased nonskin cancer risk and increased risk of cancer death. Conversely, in men, higher serum iron concentrations were associated with decreased risk of nonskin cancer. The molecular basis for the observed differences in the association between serum iron and nonskin cancer risk is unclear.

[1]  Xifeng Wu,et al.  High serum iron is associated with increased cancer risk. , 2014, Cancer research.

[2]  J. Beilby,et al.  Factors that affect serum levels of ferritin in Australian adults and implications for follow-up. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  M. Aapro,et al.  Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review. , 2014, Critical reviews in oncology/hematology.

[4]  A. Agudo,et al.  Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[5]  I. Lawrance,et al.  Dietary Iron Enhances Colonic Inflammation and IL-6/IL-11-Stat3 Signaling Promoting Colonic Tumor Development in Mice , 2013, PloS one.

[6]  L. Holmberg,et al.  Iron metabolism and risk of cancer in the Swedish AMORIS study , 2013, Cancer Causes & Control.

[7]  F. Torti,et al.  Cellular iron metabolism in prognosis and therapy of breast cancer. , 2013, Critical reviews in oncogenesis.

[8]  D. Albanes,et al.  Iron in Relation to Gastric Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[9]  M. Tevfik Dorak,et al.  Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue , 2012, Front. Gene..

[10]  A. Jakubowska,et al.  Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study , 2012, Cancer Causes and Control.

[11]  L. Weinehall,et al.  Iron Biomarkers in Plasma, HFE Genotypes, and the Risk for Colorectal Cancer in a Prospective Setting , 2012, Diseases of the colon and rectum.

[12]  L. Liang,et al.  Enigmatic sex disparities in cancer incidence , 2012, European Journal of Epidemiology.

[13]  Qing Yang,et al.  Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. , 2011, Free radical biology & medicine.

[14]  R. Sinha,et al.  Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. , 2010, The American journal of clinical nutrition.

[15]  M. Willingham,et al.  Ferroportin and iron regulation in breast cancer progression and prognosis. , 2010, Science translational medicine.

[16]  D. English,et al.  HFE C282Y homozygotes are at increased risk of breast and colorectal cancer , 2010, Hepatology.

[17]  C. McCarty,et al.  Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2009, British Journal of Cancer.

[18]  S. Toyokuni,et al.  Role of iron in carcinogenesis: Cancer as a ferrotoxic disease , 2009, Cancer science.

[19]  P. Lavori,et al.  Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. , 2008, Journal of the National Cancer Institute.

[20]  Matthew W. Knuiman,et al.  Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. , 2008, The American journal of cardiology.

[21]  R. Sinha,et al.  Iron and colorectal cancer risk in the α‐tocopherol, β‐carotene cancer prevention study , 2006 .

[22]  B. Wells,et al.  Iron, lipids, and risk of cancer in the Framingham Offspring cohort. , 2005, American journal of epidemiology.

[23]  A. Mainous,et al.  Transferrin Saturation, Dietary Iron Intake, and Risk of Cancer , 2005, The Annals of Family Medicine.

[24]  S. Larsson,et al.  Re: Heme iron, zinc, alcohol consumption, and risk of colon cancer. , 2005, Journal of the National Cancer Institute.

[25]  J. Blumberg,et al.  Dietary Iron Promotes Azoxymethane-Induced Colon Tumors in Mice , 2004, Nutrition and cancer.

[26]  W. Rayford,et al.  Serum ferritin levels and transferrin saturation in men with prostate cancer. , 2004, Journal of the National Medical Association.

[27]  J. Klaunig,et al.  The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.

[28]  J. Liao,et al.  Dietary Iron Supplementation Enhances DSS-Induced Colitis and Associated Colorectal Carcinoma Development in Mice , 2002, Digestive Diseases and Sciences.

[29]  M. Knuiman,et al.  Effects of Body Iron Stores and Haemochromatosis Genotypes on Coronary Heart Disease Outcomes in the Busselton Health Study , 2002, Journal of cardiovascular risk.

[30]  A. J. Bass,et al.  Population‐based linkage of health records in Western Australia: development of a health services research linked database , 1999, Australian and New Zealand journal of public health.

[31]  E. Riboli,et al.  Iron intake, body iron stores and colorectal cancer risk in women: a nested case‐control study , 1999, International journal of cancer.

[32]  J. Cade,et al.  Case-control study of breast cancer in south east England: nutritional factors. , 1998, Journal of epidemiology and community health.

[33]  J. Liehr,et al.  Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites: a mechanism of induction of free radical damage by estrogen. , 1997, Archives of biochemistry and biophysics.

[34]  L. Anderson,et al.  Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats. , 1997, Carcinogenesis.

[35]  R. Sandler,et al.  Iron intake and the risk of colorectal cancer. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[37]  A. Reunanen,et al.  Body iron stores and risk of cancer , 1994, International journal of cancer.

[38]  J. Beilby,et al.  Transferrin index: an alternative method for calculating the iron saturation of transferrin. , 1992, Clinical chemistry.

[39]  W. Blot,et al.  Serum ferritin and stomach cancer risk among a japanese population , 1991, Cancer.

[40]  M. Stahlhut,et al.  Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. , 1988, Cancer research.

[41]  A. Sonnenberg,et al.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.